Empowered by our foundational technology platforms, Empirico is discovering and developing novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease.

Exceptional internal expertise and capabilities in siRNA medicines, augmented by external capabilities in other modalities, drives Empirico’s ever-growing pipeline of differentiated clinical and preclinical programs for common diseases with unmet need.

Our dedicated team of physicians, biologists, chemists, data scientists, and drug developers is working hard to discover a new generation of precision medicines for patients.